Compare · MDLN vs PFSA
MDLN vs PFSA
Side-by-side comparison of Medline Inc. (MDLN) and Profusa Inc. (PFSA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and PFSA operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 74191.0x PFSA ($648,042).
- Over the past year, MDLN is down 11.8% and PFSA is down 100.0% - MDLN leads by 88.2 points.
- Both names hit the wire about 7 times in the past 4 weeks.
- MDLN has more recent analyst coverage (25 ratings vs 0 for PFSA).
PerformanceMDLN-11.77%PFSA-99.87%
2025-12-17+0.00%2026-10-16
- Company
- Medline Inc.
- Profusa Inc.
- Price
- $35.95-1.74%
- $1.05-15.32%
- Market cap
- $48.08B
- $648,042
- 1M return
- +11.97%
- -33.96%
- 1Y return
- -11.77%
- -99.95%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- News (4w)
- 7
- 7
- Recent ratings
- 25
- 0
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M
Latest PFSA
- Profusa Receives ISO 13485:2016 Certificate from GMED
- SEC Form 8-K filed by Profusa Inc.
- SEC Form 8-K filed by Profusa Inc.
- Profusa Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Here’s What Investors Are Watching, Including $20 Price Target Bombshell
- Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October
- Profusa Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Profusa Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Profusa Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Profusa, Inc. Receives Nasdaq Compliance Determination